Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Breast Neoplasms × Control Groups × Clear all

Phase

Status

Completed 18 Recruiting 9 Unknown 7 Terminated 3 Withdrawn 1 Not yet recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Anxiety Disorders 2 Unresectable Metastatic Colorectal Cancer 1 Pancreatic Neoplasms 1 Neoplasms 1 Gastrointestinal Stromal Tumors 1 Depression 1 Communication 1 Breast Neoplasms 1

Interventions

Capecitabine 14 Trastuzumab 13 pertuzumab 11 Docetaxel 11 Cyclophosphamide 11 Letrozole 10 pyrotinib 9 Paclitaxel 9 Carboplatin 9 sacituzumab govitecan 7 abemaciclib 7 Fulvestrant 7 trastuzumab deruxtecan 6 palbociclib 6 Radiotherapy 6 Epirubicin 6 Drug Therapy 6 eribulin 5 dalpiciclib 5 Tamoxifen 5 Standard of Care 5 Neoadjuvant Therapy 5 Anastrozole 5 Vinorelbine 4 Sentinel Lymph Node Biopsy 4 Doxorubicin 4 ribociclib 3 pembrolizumab 3 exemestane 3 dapagliflozin 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07042737 2025-06-29

Menopause

Inonu University

Phase NA Not yet recruiting

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡